General Information of Drug (ID: DM83EK9)

Drug Name
ISIS 6958 Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DM83EK9

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PNT-300 DM8WJQ0 Solid tumour/cancer 2A00-2F9Z Investigative [2]
ISIS 7453 DMOX7FJ Discovery agent N.A. Investigative [1]
ISIS 6957 DMTHO4A Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
KRAS messenger RNA (KRAS mRNA) TTM8FR7 RASK_HUMAN Not Available [1]

References

1 US patent application no. 5,965,722, Antisense inhibition of ras gene with chimeric and alternating oligonucleotides.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2824).
3 Antisense oligonucleotides demonstrate a dominant role of c-Ki-RAS proteins in regulating the proliferation of diploid human fibroblasts. J Biol Chem. 1996 Nov 8;271(45):28259-65.